ALEXANDRIA, Va., Oct. 6 -- United States Patent no. 12,753,175, issued on Oct. 6, was assigned to Hoffmann-La Roche Inc. (Branchburg, N.J.). "Process for the preparation of (9S)-2-bromo-9-(2,3,4-trif... Read More
ALEXANDRIA, Va., Oct. 6 -- United States Patent no. 12,753,176, issued on Oct. 6, was assigned to TIANJIN JIKUN MEDICAL TECHNOLOGY Co. LTD. (China). "Compound, preparation method thereof, and use the... Read More
ALEXANDRIA, Va., Oct. 6 -- United States Patent no. 12,753,177, issued on Oct. 6, was assigned to SYDDANSK UNIVERSITTET (Denmark). "Substituted 1,2,3-triazoles as antibacterial and antifungal pleurom... Read More
ALEXANDRIA, Va., Oct. 6 -- United States Patent no. 12,753,178, issued on Oct. 6, was assigned to Recurium IP Holdings LLC (San Diego). "Methods of making WEE1 inhibitor compounds" was invented by Pe... Read More
ALEXANDRIA, Va., Oct. 6 -- United States Patent no. 12,753,179, issued on Oct. 6, was assigned to SHENZHEN KANGSU PHARMACEUTICAL TECHNOLOGY Co. LTD. (China). "FGFR inhibitor compound and use thereof"... Read More
ALEXANDRIA, Va., Oct. 6 -- United States Patent no. 12,753,180, issued on Oct. 6, was assigned to The Board of Regents of The University of Texas System (Austin, Texas). "Sirt6 activators" was invent... Read More
ALEXANDRIA, Va., Oct. 6 -- United States Patent no. 12,753,181, issued on Oct. 6, was assigned to QURIENT Co. LTD. (Gyeonggi-Do, South Korea). "Compounds for degradation of cyclin-dependent kinase 7(... Read More
ALEXANDRIA, Va., Oct. 6 -- United States Patent no. 12,753,182, issued on Oct. 6, was assigned to Semiconductor Energy Laboratory Co. Ltd. (Atsugi, Japan). "Organic compound, light-emitting device, l... Read More
ALEXANDRIA, Va., Oct. 6 -- United States Patent no. 12,753,183, issued on Oct. 6, was assigned to UNIVERSITY OF PUERTO RICO (San Juan, Puerto Rico). "1,5-disubstituted 1,2,3-triazoles are inhibitors ... Read More
ALEXANDRIA, Va., Oct. 6 -- United States Patent no. 12,753,184, issued on Oct. 6, was assigned to GEn1E Lifesciences Inc. (Palo Alto, Calif.). "P38alpha mitogen-activated protein kinase inhibitors" w... Read More